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SEC18 gene function is required for secretory protein transport between the endoplasmic reticulum (ER) and
the Golgi complex. We cloned the SEC18 gene by complementation of the secl8-1 mutation. Gene disruption
has shown that SEC18 is essential for yeast cell growth. Sequence analysis of the gene revealed a
2,271-base-pair open reading frame which could code for a protein of 83.9 kilodaltons. The predicted protein
sequence showed no significant similarity to other known protein sequences. In vitro transcription and
translation of SEC18 led to the synthesis of two proteins of approximately 84 and 82 kilodaltons. Antisera raised
against a Secl8-0I-galactosidase fusion protein also detected two proteins (collectively referred to as Secl8p) in
extracts of 35S-labeled yeast cells identical in size to those seen by in vitro translation. Mapping of the 5' end
of the SEC18 mRNA revealed only one major start site for transcription, which indicates that the multiple
forms of Secl8p do not arise from mRNAs with different 5' ends. Results of pulse-chase experiments indicated
that the two forms of Secl8p are not the result of posttranslational processing. We suggest that translation
initiating at different in-frame AUG start codons is likely to account for the presence of two forms of Secl8p.
Hydrophobicity analysis indicated that the proteins were hydrophilic in nature and lacked any region that
would be predicted to serve as a signal sequence or transmembrane anchor. Although potential sites for
N-linked glycosylation were present in the Secl8p sequence, the sizes of the in vivo SEC18 gene products were
unaffected by the drug tunicamycin, indicating that Secl8p does not enter the secretory pathway. These results
suggest that Secl8p resides in the cell cytoplasm. While preliminary cell fractionation studies showed that
Secl8p is not associated with the ER or Golgi complex, association with a 100,000 x g pellet fraction was
observed. This suggests that Secl8p may bind transiently to small vesicles such as those presumed to participate
in secretory protein transport between ER and the Golgi complex.
The temperature-conditional yeast sec mutants define a
set of functions required for secretory protein transport (20,
25). Nine sec genes, including secl8, have been shown to
cause a block in the transport of secretory proteins between
the yeast endoplasmic reticulum (ER) and the Golgi complex
(7, 19). In secl8-1 mutant yeast cells, secretory protein
traffic is blocked at the level of the ER on a shift to the
nonpermissive growth temperature (37°C). This is true for
both secreted enzymes, such as invertase, and vacuolar
proteases, like carboxypeptidase Y (CPY), which use the
secretory pathway for intracellular localization (28). In sec18
mutant cells, ER function per se is not impaired. Protein
translocation across the ER membrane continues at the
nonpermissive temperature, as do secretory protein process-
ing activities such as signal sequence cleavage and core
oligosaccharide addition. However, protein modifications
characteristic of the Golgi complex, such as the addition of
outer chain mannose residues, are not observed on the
accumulated secretory proteins (7, 19). Electron microscopy
has shown that secl8 mutant cells accumulate exaggerated
forms of the ER (19, 25). When secl8 mutant cells are
returned to the permissive temperature (230C), accumulated
secretory proteins undergo transport and processing through
the remainder of the secretory pathway (20). Accumulated
invertase is released at the cell surface as the normal, active,
highly glycosylated enzyme. Together, the specificity of the
secl8-1 defect as well as its reversibility indicate that the
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secl8 mutant accumulates an authentic intermediate in the
protein secretion pathway. Because interorganelle traffic
between secretory compartments likely occurs via vesicle
carriers, the SEC18 gene is presumed to encode a function
that is involved in either the selective packaging of secretory
proteins into carrier vesicles or the transport and fusion of
such vesicles with the correct Golgi complex target mem-
brane.
We report the cloning and sequencing of the SEC18 gene.
In addition, we characterized both the mRNA and two
protein products (referred to collectively as Secl8p) encoded
by this gene. Together, our observations suggest that Secl8p
acts on the vesicle carriers that shuttle membrane and
protein between ER and Golgi complex compartments.
MATERIALS AND METHODS
Strains. Escherichia coli Mc1061 [F- araD139
A(araABOIC-leu)7679 AlacX74 galU galK rpsL hsdR] (3)
was used for cloning and fusion protein production, and
JM101 was used for M13 phage growth for sequencing.
Saccharomyces cerevisiae strains used were SEY2101
(MATa ura3-52 leu2-3,112 suc2-A9 ade2-1) (6), SEY5186
(MATot secUl8-1 ura3-52 leu2-3,112) (5), and SEY6201 (MATa
ira3-52 leu2-3,112 his3-A200 trpl-A901 suc2-A9 ade2-101)
(this study). Strains were grown in standard medium prepa-
rations (16, 27).
Materials. Restriction enzymes, T4 DNA ligase, Bal 31
nuclease, mung bean nuclease, and 5-bromo-4-chloro-3-
indolyl-o-D-galactoside (Xgal) were purchased from either
New England BioLabs, Inc. (Beverly, Mass.) or Bethesda
Research Laboratories (Gaithersburg, Md.) and were used
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as recommended by the suppliers. Deoxy- and dideoxynu-
cleotides were purchased from Pharmacia Fine Chemicals
(Piscataway, N.J.). Universal sequencing primer was a gift
from M. Simon. [32P]dATP, [a-thio-35S]dATP, Na35SO4,
and Trans35S label (a hydrolysate of E. coli grown in 35SO4
containing -70% [35S]methionine and 20o [35S] cysteine)
were purchased from ICN Biochemicals (Irvine, Calif.).
GeneScreen was purchased from Dupont, NEN Research
Products (Boston, Mass.). Sodium dodecyl sulfate (SDS)-
polyacrylamide gel electrophoresis (PAGE) supplies and
Western blot reagents (horseradish peroxidase [HRP] sys-
tem) were from Bio-Rad Laboratories (Richmond, Calif.).
The RNA cap analog [m7G(5')ppp(5')G], ribonucleotides,
and yeast translation extracts were gifts from E. Greyhack.
SP6 RNA polymerase and RNasin were from Promega
Biotech. Oxylyticase was purchased from Enzogenetics
(Corvallis, Oreg.). Antiserum against P-galactosidase was a
gift from T. Silhavy. Antiserum against the P subunit of
mitochondrial F1-ATPase was a gift from M. Douglas. An-
tiserum against CPY was from Klionsky et al. (10).
Recombinant DNA constructions. Preparation of DNA,
restriction digestions, agarose gel electrophoresis, and clon-
ing of DNA fragments were done as described previously
(14).
DNA sequencing. DNA sequencing was done by standard
dideoxy chain termination methods (24) by using Bal 31
deletion subclones of SEC18 in M13mpl9. DNA and protein
sequences were compiled and analyzed with computer pro-
grams written by K. Eakle (unpublished data). Homology
searches of the National Biomedical Research Foundation
Protein Identification Resource data base were done on
BIONET by using the XFASTP program (13).
Antisera production. SEC18-lacZ fusions were generated
by cloning Bal 31 nuclease digestions of the 3.0-kilobase (kb)
BamHI-HindIII fragment into SmaI-cut pORF5. Clones
were screened for overproduction of P-galactosidase activity
on ampicillin-containing plates with Xgal. Plasmid DNA was
prepared from candidate clones and checked for SEC18
inserts by restriction mapping. Whole-cell extracts of E. coli
with candidate plasmids were run on SDS-polyacrylamide
gels (11) and evaluated by both Western blotting (30) with
primary antisera against P-galactosidase (visualized by the
HRP color reaction system) and staining with Coomassie
blue to identify fusion protein bands and to estimate the
extent of overproduction.
Fusion proteins were purified by growing E. coli with the
fusion construction pORF18-40 to the stationary phase.
Cells (250 OD6. units; 1 OD6. unit of cells equals the cells
in 1 ml of a culture grown to an optical density at 600 nm of
1.0) were pelleted and suspended at 10 OD6. units per ml in
50 mM Tris (pH 8.0)-10 mM EDTA-10 mM dithiothreitol.
Cells were lysed with a French press and spun at 6,000 x g
for 20 min at 4°C in a rotor (JA-20), and the supernatant was
spun at 170,000 x g for 30 min at 15°C in a rotor (Ti7O.1).
Membrane pellets were suspended in a small volume of
buffer, and samples of the fractions were assayed for -
galactosidase activity at appropriate dilutions (16). Greater
than 50%o of the total P-galactosidase activity of the fusion
proteins was associated with the membrane pellet, which
yielded the equivalent of 2 to 3 mg of P-galactosidase
activity. The largest fusion band was fragment purified from
5% SDS-polyacrylamide preparative gels that were stained
with Coomassie blue. Commercially available P-galacto-
sidase was also run on the preparative gels and was used to
estimate the amount of fusion protein recovered. Fusion
bands were homogenized, dialyzed against phosphate-buff-
ered saline, and mixed with an equal volume of 1% agarose
in phosphate-buffered saline. Approximately 50 jig of fusion
protein was injected subcutaneously into young New Zea-
land White male rabbits weekly for 4 weeks, and then once
every 2 weeks for 4 months. Antisera were initially evalu-
ated for their ability to react in a Western blot procedure to
the Secl8-3-galactosidase fusion protein that was present in
a whole-cell SDS-polyacrylamide gel extract of E. coli
Mc1061 transformed with the pORF18-40 fusion construct.
Attempts at identifying the yeast SEC18 gene product in a
similar fashion from extracts of whole yeast cells by Western
blotting were unsuccessful. Following identification of the
Secl8 protein by in vitro translation, the antisera were found
to specifically immunoprecipitate the [35S]methionine-la-
beled in vitro translation product, as well as proteins with
the same mobility on SDS-PAGE from extracts of yeast cells
labeled with 35SO4. A titration curve was generated for the
SEC18 antisera, as well as for the other antisera used in this
study, by immunoprecipitating 35SO4 labeled whole yeast
cell extracts (1 OD6. unit per sample) with increasing
amounts of antiserum. With this information, levels of
antiserum were chosen which were in excess over the
amount of the labeled proteins to be precipitated along with
an amount of protein A-Sepharose CL4B sufficient to bind
all the antiserum present, in order to ensure quantitative
recovery. Precipitation with this same amount of antiserum
against the Secl8p produced in yeast cells containing the
SEC18 gene on a multicopy plasmid with a 2,tm origin of
replication showed that this level of antiserum was sufficient
to precipitate an eightfold excess of labeled SEC18 gene
product. Greater amounts of antiserum showed that the total
level of Secl8p overproduction was about 20-fold with the
SEC18 gene on a multicopy plasmid.
Northern blot and 5' and 3' end mapping. Yeast RNA was
prepared by a modification of a previously described proce-
dure (4). Yeast cells were grown in YNB-glucose medium
(27) to the mid-log phase. Yeast (50 OD6. units) were
pelleted, washed with distilled H2G, and suspended in 2 ml
of 0.5 M NaCI-0.2 M Tris hydrochloride (pH 7.5)-10 mM
EDTA-1% SDS. Cells were added to 15-ml polypropylene
tubes with 2 g of acid-washed glass beads and 2 ml of
phenol-CHCl3 (1:1 [vol/vol]). Cells were chilled on ice,
vortexed extensively, and spun at 12,000 x g at 40C for 10
min in a rotor (JA-20). The supernatant was reextracted
twice more with phenol-CHCl3, and the RNA was precip-
itated with 2.5 volumes of cold ethanol. Pellets were washed
with 70% ethanol, dried, and redissolved in 10 mM Tris
hydrochloride (pH 7.5)-i mM EDTA (TE). RNA recovery
was measured by determining the optical density at 260 nm.
Sodium acetate was added to 0.3 M, ethyl alcohol was added
to 70%, and RNA was stored at -800C. Poly(A)+ RNA was
isolated by binding to oligo(dT)-cellulose (Sigma Chemical
Co., St. Louis, Mo.) in the presence of 0.5 M LiCl, washing
extensively with the high salt buffer, and eluting with TE.
RNA was run on formaldehyde-1% agarose gels and trans-
ferred to GeneScreen (14). Size standards were generated by
32p end-labeling lambda DNA which was cut with EcoRI and
HindIII. [32P]RNA probes were made by transcribing the
noncoding strand of our SEC18 clone in pSP64 with SP6
RNA polymerase with [32P]UTP and were hybridized to the
blot as described previously (15).
Mapping at the 5' end was done by using a 32P-end-labeled
oligonucleotide (5'-GGGAAATCATTTGGT-3', comple-
mentary to bases 681 to 695 of the DNA sequence), which
was hybridized to a single-stranded M13-SECJ8 subclone
and extended with the Klenow fragment of E. coli DNA
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polymerase I. The reaction was then digested with HindIl,
and the probe was fragment purified on a 6 M urea-5%
acrylamide gel. The probe (105 cpm) was hybridized to 25 ,ug
of total yeast RNA in 80% formamide-40 mM PIPES [pipe-
razine-N,N'-bis(2-ethanesulfonic acid); pH 6.81-400 mM
NaCI-1 mM EDTA in a total volume of 25 ,u1 overlaid with
50 RI1 of mineral oil. The hybridization reaction mixture was
heated at 85°C for 5 min and then incubated at 42°C over-
night (12). The reaction mixture was diluted with 400 p.1 of 50
mM sodium acetate (pH 5.0)-10 mM NaCI-1 mM ZnSO4 and
digested with 50 U of mung bean nuclease for 1 h at 37°C (8).
The reaction was phenol extracted twice and ethanol precip-
itated with glycogen as a carrier. To identify the size of the
digestion products of the hybridization reaction, dideoxy
sequencing reactions were carried out with the 32P-end-
labeled oligonucleotide as the primer and label in the reac-
tions. The sequencing reactions and the digestion products
of the hybridization reaction were run on a 6% sequencing
gel.
Mapping at the 3' end was performed as described above
for the mapping of the 5' end. The probe was a [32P]UTP-
labeled SP6 RNA polymerase transcript from the HindlIl
site of our SEC18 clone to the PstI site at position 2235.
Hybridization was done as described above for 5' end
mapping, except that overnight incubation was done at 50°C.
Samples were digested with mung bean nuclease as de-
scribed above and run on a 5% sequencing gel, with 32P-end-
labeled lambda phage fragments and undigested probe used
as size standards.
In vitro transcription and translation. Yeast in vitro trans-
lation extracts were prepared as described previously (31)
and treated with micrococcal nuclease. RNA was generated
by SP6 RNA polymerase runoff transcription of the mini-
mum complementing subclone of SEC18 cloned in pSP65,
using ribonucleotide mixes with and without 0.5 mM
m7G(5')ppp(5')G to give a capped mRNA (15). In vitro
translation was performed as described previously (31) with
10 to 15 ,uCi of [35S]methionine per reaction. Translation
products were run on SDS-12% polyacrylamide gels (5%
stacking gel). Gels were fixed, stained, treated with Auto-
Flour (National Diagnostics, Somerville, N.J.), and dried
before autoradiography on XAR film (Eastman Kodak Co.,
Rochester, N.Y.).
Immunoprecipitation. Yeast cells were grown to the mid-
log phase in a defined medium (10) containing 100 p.M S04.
One OD6. unit of cells per immunoprecipitation sample
were pelleted, washed with distilled H20, and suspended in
0.5 ml of sulfate-free medium-1 mg of bovine serum albumin
per ml. Samples were incubated for 30 min at 30°C with
shaking, and 100 to 200 p.Ci of 35 O4 per OD6. unit of
cells was added. Cells were labeled for 30 min at 30°C with
shaking and unlabeled S04 was added to a final concentra-
tion of 50 mM. Labeling or chase was stopped by the
addition of trichloroacetic acid to 5%, and samples were put
on ice for 20 min. Samples were pelleted in a microfuge for
5 min, and the pellets were washed twice with cold acetone
and dried. SDS boiling buffer (1% SDS, 50 mM Tris [pH 7.5],
1 mM EDTA, 100 p.1 per sample) and glass beads were
added, and the samples were vortexed extensively and
boiled for 3 min. One milliliter of Tween-IP buffer (50 mM
Tris [pH 7.5], 150 mM NaCl, 0.1 mM EDTA, 0.5% [wt/vol]
Tween 20) was added. Samples were vortexed and micro-
fuged for 15 min in the cold. Supernatant (0.9 ml) was
carefully removed, and 1 to 20 p.1 of the appropriate anti-
serum was added. Samples were rocked gently at 4°C for 3 h
and 100 p.1 of 3.6% (wt/vol) protein A-Sepharose CL4B
slurry was added. Samples were rocked for an additional 0.5
h at 4°C and pelleted. The pellets were washed (1 ml per
wash) twice with Tween-IP buffer, twice with Tween-urea
buffer (100 mM Tris [pH 7.5], 200 mM NaCl, 0.5% [wt/vol]
Tween 20, 2 M urea), once with 1% P-mercaptoethanol, and
once with 0.1% SDS. SDS-PAGE sample buffer (50 p.1) was
added, and the samples were boiled for 5 min before they
were loaded onto an SDS-8% polyacrylamide gel (4% stack-
ing gel).
Fractionation. Yeast cells to be labeled were pelleted,
washed with distilled H20, and incubated with 100 mM Tris
(pH 8.5)-25 mM dithiothreitol for 5 min at 30°C. Cells were
pelleted, washed with distilled H20, and spheroplasted with
1 p.g of oxylyticase per OD6. unit of cells in sulfate-free
medium, which was adjusted to pH 7.5 and which contained
1.2 M sorbitol for osmotic support (22). Spheroplasts were
pelleted gently, washed, suspended with sulfate-free me-
dium (pH 5.5) containing 1.2 M sorbitol, and labeled with 50
to 100 p.Ci of Trans35S label per OD6. unit of cells for 30 min
at 30°C. Cells were pelleted at 500 x g, suspended gently in
100 p.1 of 1.2 M sorbitol-100 mM KPO4 (pH 7.5)-10 mM
EDTA, and lysed by rapid dilution with 1 ml of 0.25 M
sucrose-10 mM Tris (pH 7.5)-10 mM EDTA-1 mM phenyl-
methylsulfonyl fluoride-1 mg of bovine serum albumin per
ml. One OD6. unit of the lysed cells was precipitated with
trichloroacetic acid for a whole-cell sample. Unlysed cells
were pelleted at 2,000 x g for 2 min, and the supernatant was
centrifuged at 13,000 x g for 15 min at 4°C. Supernatant (0.8
ml) from the microfuge spin was carefully removed and spun
at 100,000 x g in a rotor (Ti70.1). Excess supematant was
removed carefully from the microfuge pellet, which was
suspended in 100 p.1 of SDS boiling buffer, and boiled for 3
min. The supernatant from the 100,000 x g spin was precip-
itated with trichloroacetic acid on ice for 20 min, and the
100,000 x g pellet was suspended in 100 p.1 of SDS boiling
buffer and boiled for 3 min. Samples were immunoprecipi-
tated as described above.
RESULTS
Characterization and cloning of the SEC18 locus. The
secl8-1 mutation in S. cerevisiae has been shown to cause a
block in the transfer of proteins from the ER to the Golgi
complex on a shift to the nonpermissive temperature. This
block results in the accumulation of ER, as identified by
thin-section electron microscopy (19, 20, 25). Proteins that
transit the secretory pathway also accumulate with modifi-
cations that are consistent with their presence inside the ER,
that is, with signal sequences removed and only core glyco-
sylation units added to the protein backbone. This block is
also reversible. The invertase that accumulated under these
conditions has been shown to resume transport through the
secretory pathway when it is returned to the permissive
temperature (20). The speed with which ER transport is
blocked by the secl8-1 mutation is demonstrated in Fig. 1.
Invertase was immunoprecipitated from secl8-1 yeast cells
that were grown under various conditions. In Fig. 1, lane 1
shows the size of unglycosylated invertase produced at the
permissive temperature in the presence of tunicamycin. To
determine the rate of onset of the block in secretory protein
traffic in sec18-1 mutant yeast cells, we shifted cells to 37°C
for only 10 min before they were labeled with 31SO4. Under
these conditions, invertase accumulated as three distinct
bands between 78,000 and 84,000 daltons (Fig. 1, lane 2).
These bands corresponded to invertase, which varies in the
total number of core oligosaccharide units added to the
protein backbone (each core increases the apparent molec-
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FIG. 1. secl8-1 mutant cells were grown in 100 ,uM S04 medium
with 2% glucose. Cells were pelleted, washed with distilled H20,
and suspended in sulfate-free medium with 0.2% glucose for 30 min
before they were labeled to induce invertase production. Cells were
labeled with 0.5 mCi of "sSO4 per ml for 20 min and chased for 20
min following the addition of (NH4)2SO4 to 50 mM. kd, Kilodaltons.
ular weight of the protein by 2 to 2.5 kilodaltons). At the
permissive temperature (Fig. 1, lane 3), sec18-1 mutant cells
process the labeled invertase to its highly glycosylated
secreted form during passage through the Golgi complex.
Thus, the secl8-1 mutation results in a rapid block in
secretory protein traffic at some stage after ER translocation
and core oligosaccharide modification of secretory proteins.
Based on the results of morphology studies, the rapid and
specific block in secretory protein movement, as well as the
reversibility of the secl8 mutant block, we reasoned that the
SEC18 gene is likely to code for a function that is directly
involved in protein transfer between the ER and Golgi
complex. To investigate this function, the SEC18 gene was
cloned by complementation of the secl8-1 mutation with a
genomic library of yeast DNA fragments in the multicopy
vector YEp13 (18). Subcloning and further complementation
analysis showed that the complementing activity resides on
a 3.0-kb BamHI-HindIII fragment. Because of a lack of
restriction sites on one side of the clone, a library of Bal 31
deletion subclones was constructed which extended from
either end of the BamHI-HindIII fragment. Complementa-
tion analysis with these fragments cloned into the low-copy-
number shuttle vector pSEYC58 (CEN4 ARSI) revealed that
500 base pairs (bp) of DNA at the BamHI side of the
fragment could be deleted without destroying the comple-
menting activity (Fig. 2B). Deletion of as little as 200 bp from
the HindIll side of the fragment was sufficient to destroy
complementing activity.
To confirm that our clone carried the authentic SEC18
gene and not a suppressor locus, we substituted the LEU2
gene on a 2.1-kb HpaI fragment for a 300-bp HpaI fragment
in the central region of the clone. A linear fragment with
SEC18 homology at both ends was transformed into the
diploid strain SEY6201/SEY5186 (aJa leu2-3, 1121leu2-3,112
SEC18/secl8-1), and Leu+ transformants were selected.
Approximately 50% of the Leu+ transformants simulta-
neously acquired the recessive Ts phenotype, indicating that
the SEC18 gene of one homolog was disrupted (23). Tetrad
dissections of spores from the Ts diploid strains showed 2:2
segregation of secl8(Ts)/Leu-: dead (Leu+) spores per tet-
rad (n = 7). In addition, viable random spores from such
diploids were all found to be secl8(Ts)/Leu- (200 haploid
spores). These results indicate that our clone maps to the
SEC18 chromosomal locus and that SEC18 is an essential
gene. Examination of the dead spores showed that although
many germinated and went through one cell division, none
grew beyond the two-cell stage, suggesting that the intracel-
lular pool of SEC18 gene product is sufficient for spore
germination but not large enough to sustain vegetative
growth.
Further evidence that our clone contained the SEC18 gene
was obtained by transforming secl8-1 mutant yeast cells
with a yeast integrating plasmid (YIp5 vector) containing a
noncomplementing fragment of the SEC18 clone. This plas-
mid was restricted within the SEC18 DNA to direct integra-
tion to the homologous chromosomal region (21). Following
selection of Ura+ transformants (all of which remained
temperature sensitive), genomic DNA was prepared from
integrants and restriction digested with an enzyme (EcoRI)
which was expected to release the YIp5 vector together with
adjacent SEC18 sequences. The resulting DNA fragments
were then ligated in dilute solution to recircularize the DNA,
transformed into E. coli, and selected on the basis of
ampicillin resistance. Restriction mapping of the resultant
clones showed that they had, in fact, captured the entire
secl8 locus. These clones were shown to contain a func-
tional temperature-sensitive allele of the secl8 gene by
transferring the gene to a yeast replicating vector (pSEYC58)
and transformation into the SECJ8::LEU2/secl8(Ts) diploid
strain. These transformants remained temperature sensitive
and on sporulation were able to give Leu+ Ura' (Ts)
haploids, indicating functional expression of atemperature-
sensitive copy of secl8 from the plasmid. To identify the
approximate position of the temperature-sensitive lesion in
the secl8-1 mutant gene, restriction fragments were ex-
changed between the wild-type and secl8(Ts) clones. After
transformation into secl8-1 mutant yeast cells, the hybrid
gene constructs were scored for whether they encoded a Ts
or wild-type form of Secl8p. Based on results of these
studies, the secl8-1 mutation was found to unambiguously
map to a 351-bp ClaI fragment (Fig. 2A). This placed the Ts
mutation within the open reading frame of our SEC18 clone.
DNA sequence of SEC18. The entire 3,042-bp BamHI-
HindIII SEC18-complementing DNA clone was sequenced
by using standard dideoxy sequencing techniques, and the
library of Bal 31 deletion subclones described above (Fig.
2C). The sequence (Fig. 3) revealed a 2,271-bp open reading
frame which could potentially code for a protein product of
83,903 daltons. A search of the NBRF protein sequence data
base showed no significant similarity between the predicted
protein sequence and those of other known proteins (13).
The position of the start of the smallest complementing
subclone was only 35 bp upstream of the first ATG codon of
the open reading frame, leaving little room for a SEC18
promoter. Yeast gene promoters normally consist of a
TATA sequence element that is usually 40 to 120 bases
upstream from the site of transcription initiation and an
additional enhancerlike element (upstream activating se-
quence) 5' to the TATA box (29). Possible TATA sequences
are found at positions 516 to 522 and 529 to 533, which are
only 10 to 20 bp upstream of the open reading frame. No
candidate sequences corresponding to an upstream activat-
ing sequence element in the region 5' to the TATA boxes
included in the smallest complementing clone were identi-
fied. Two additional ATG codons were present in the open
reading frame 54 and 63 bp downstream of the first ATG
codon. Combined, this information led us to question
whether the transcriptional start point for the gene included
the first ATG codon of the open reading frame.
Temperature 2
Tunicamycin
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FIG. 2. (A) Restriction map of a SEC18 clone showing the position of the open reading frame as determined by DNA sequencing.
Restriction enzyme abbreviations: B, BamHI; P, PstI; K, KpnI; Hp, HpaI; H, Hindlil; C, ClaI; R, EcoRI. The position of the mutation
leading to the temperature-sensitive phenotype of sec18-1 is indicated with double arrows. (B) Complementation analysis of SEC18 subclones.
Restriction fragments or Bal 31 deletions were cloned into pSEYC58 (CEN4 ARSI URA3) and transformed into strain SEY5186 by LiCl yeast
transformation. Transformants were selected for Ura+ and tested for growth at 25 and 37°C. A plus sign indicates temperature-resistant
transformants, and a minus sign indicates temperature-sensitive transformants. (C) Sequencing strategy used for DNA sequencing. Each
arrow indicates independent subclones obtained by Bal 31 digestion of the 3.0-kb BamHI-HindIII fragment from either end cloned into
M13mp19. The entire BamHI-HindIII SEC18 fragment was cloned into M13mp8 and M13mp9 to obtain a sequence from the BamHI site at
the 5' end of the clone and from the HindlIl site at the 3' end of the clone, respectively. (D) Comparison of the results of end mapping of the
SEC18 mRNA with the open reading frame of the DNA sequence. Numbers in parentheses represent the positions in the nucleotide sequence.
The position of the 5' end is mapped to ±2 nucleotides; the position of the 3' ends are ±15 nucleotides.
Analysis of SEC18 mRNA. Northern blots (Fig. 4A) with
single-stranded probes from either strand of the SEC18 clone
confirmed that the only transcript from this region of DNA
was a poly(A)+, 2,500-nucleotide mRNA in the orientation
of the open reading frame seen in the DNA sequence. End
mapping experiments of the 5' end of the SEC18 transcript
were done with a 32P-end-labeled single-stranded probe and
mung bean nuclease (Fig. 4B). Results of these experiments
revealed that there is only one major initiation point for
genomic transcription, beginning almost exactly at the posi-
tion of the start of the smallest complementing subclone.
This places our predicted TATA sequences within the tran-
scribed region. Only the DNA which corresponded to the
transcribed region appeared to be necessary for complemen-
tation of the secl8(Ts) defect. Because other single- and
multicopy vectors were used to test complementation of this
subclone, it seems unlikely that complementation was due to
runon transcripts from other genes on our initial yeast
shuttle vector. While aberrant expression of SEC18 on a
plasmid vector cannot be ruled out, the observation that the
complementing subclone contained so little upstream se-
quence suggests that sequences which function in transcrip-
tion initiation may be located within the transcript or may
not be necessary for weak expression. The latter might be
explained if only very low levels of SEC18 transcription are
required for complementation of the secl8(TS) defect.
End mapping of the 3' end of the gene (data not shown)
showed two major sites of transcription termination at
approximately positions 2942 and 2956. Analysis of the
sequence downstream from the termination of the open
reading frame showed that this region conforms well to the
consensus sequence ([T-rich region] . . . TAG . . . TAGT/
TATGT ... [AT-rich region]) for yeast termination and
polyadenylation (32). The presence of three TAGT-like
sequences suggests that these may function as two overlap-
ping pairs of transcription terminators and, thus, lead to the
two major sites of termination. Note also that both transcrip-
tion termination sites were well beyond the TAA codon at
position 2812, which would terminate translation of the open
reading frames.
Identification of Secl8p in vitro and in vivo. The protein
products of the SEC18 gene were identified by in vitro
translation with a yeast translation extract and an SP6 RNA
polymerase-generated template RNA corresponding to the
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1 GGATCCAACA ACAACTGTAA ACGCCAAAGT GGGTGCAGAA 46
41 AATGATGGAC GATTCTTCCT TATTTTTGCG AACGCCTCAC ACCTTTAGAT CCTTTGGATA TGGATGATGC TTTTGATGAT ACCAATATGG GCAGCAATAG 146
141 TTCATTTAGC TTGAGCCTTC CTCGCCTTAA TCAATAATGA GCGCGCTAAA TAGTTGAATA TTTTATCTTT AATTAAATAC ATTTGCTTAT AAAGGTTGTA 246
Pat I
241 CTATTTACTT GTAGTTGATG TAGGATTCCA ATTCAATGCA CTTTAATACT CAGAGTACGC TTTATACTTC TGCAGTACCC TCTCTAAAAT GTCACCTAGT 346
341 ATTTTTTTCT CTTTACACAA CGTAGCGTCA CTAAAAAAAG GTATTTCCCA TGGGTTAATT CGGTATCACA CTATACGTTA GGCGTACCAA ATTTCGAGAT 446
*-> Niniamm Complmenmtisg Pragmmot
441 TCATGAAATT GGCTTATTCG TAGCCTTTAA GTACTACCGT GTGTTTTCTC TCAAAGATAA GAGCAAATAG TACCGTATAT TCAGCCTTTA TAAATTGAGT 546
*-> aREA Start
541 ATG TTC AAG ATA CCT GGT TTT GGA AAA GCT GCT GCA AAT CAT ACT CCA CCA GAT ATG ACA AAC ATG GAT ACC CGT ACA CGC CAT 624
1 Ha? Phe Lys lie Pro Gly Phe Gly Lys Ala Ala Ala Asn His Thr Pro Pro Asp MR? Tht Asn ME? Asp Thr Arg Thr Arg His 28
625 TTA AAG GTG TCA AAC TGT CCA AAT AAC TCC TAT GCA CTC GCA AAC GTA GCT GCT GTC TCA CCA AAT GAT TTC CCT AAT AAC ATT 768
29 Leo Lye Val Ser Asn Cys Pro Asn Asn Ser Tyr Ala Leo Ala Asn Val Ala Ala Val let Pro Asn Asp Phe Pro Asn Asn Ilie 56
769 TAT ATT ATT ATC GAT AAT TTA TTT GTT TTC ACA ACT AGA CAC TCC AAC GAC AT? CCA CCG GGA ACC ATT GGA TTT AAC GGT AAC 792
57 Tyr Ilie lie Ilie Asp Asn Leo Phe Val Phe Thr Thr Arg His Ser Asn Asp lie Pro Pro Gly Thr Ilie Gly Phe Asn Gly Asn 84
793 CAG CGT ACC TGG GGT GGT TGG TCC CTA AAT CAA GAC GTG CAA GCA AAA GCA TTT GAT TTA TTC AAG TAT TCC GGT AAG CAA TCG 876
85 Gin Arg Thr Trp Gly Gly Trp Ser Leo Asn Gin Asp Val Gin Ala Lys Ala Phe Asp Leu Phe Lys Tyr Ser Gly Lys Gin Ser 112
877 TAT CTT GGT TCA ATA GA? ATA GA? ATC TCA TTC AGA GCT AGA GGT AAG GCG GTA AGC ACG GTA TTC GAT CAA GA? GAG TTA GCC 966
113 Tyr Leo Gly Ser Ilie Asp Ilie Asp Ilie Ser Phe Arg Ala Arg Gly Lys Ala Val Ser Thr Val Phe Asp Gin Asp Gin Lee Ala 146
961 AAA CAA TTT GTT CGT TGC TAC GAA TCT CAA ATA TTT TCT CCC ACC CAG TAC CT? ATC ATG GAG TTC CAA GGC CA? ?TC TT? GAC 1644
141 Lys Gin Phe Val Arg Cys Tyr Glu Ser Gin Ile Phe Ser Pro Thr Gin Tyr Lea lie Het Gin Phe Gin Gly His POe Phe Asp 168
1645 TTA AAA AT? AGA AAT GTC CAA GCA ATC GA? TTG GGT GA? AT? GAA CCA ACC TCC GCT GTT GCA ACT GGG ATA GAG ACA AAG GGA 1128
169 Leo Lye Ilie Arg Asn Val Gin Ala Ilie Asp Leu Gly Asp Ilie Gin Pro Thr Ser Ala Val Ala Thr Gly Ilie Gin Thr Lye Gly 196
1129 AT? TTG ACA AAA CAA ACA CAA AT? AAT TTT TTC AAA GGA AGA GA? GGT TTA GTT AAT TTG AAA TCA TCA AAT TCA TTA AGA CCA 1212
197 Ilie Leo Thr Lye Gin TOn Gin Ilie Ann Phe Phe Lye Gly Arg Asp Gly Leu Val Asn Leu Lye Ser ler Asn let Leu Arg Pro 224
1213 AGA TCA AAT GCT GTG ATC AGA CCG GA? TTC AAG TT? GAA GA? TTG GGT GTC GGT GGT TTG GA? AAA GAG TTT ACT AAA AT? TTC 1296
225 Arg Ser Asn Ala Val Ilie Arg Pro Asp POe Lye Phe Gin Asp Leo Gly Val Gly Gly Leu Asp Lye Glu Phe TOn Lye Ilie Phe 252
1297 AGA AGA GCG TTT GCA AG? CGA ATC TTT CC? CC? TCA GTT ATA GAA AAA CTG GGT AT? TCT CAT GTT AAA GGT TTG CTA TTG TAC 1366
253 Arg Arg Ala Phe Ala let Arg lie Phe Pro Pro Ser Val lie Gin Lye Leu Gly Ilie let His Val Lye Gly Leu Leu Leu Tyr 266
1381 GGT CC? CCA GGT AC? GGT AAG ACC TTA A?? GCA AGA AAG AT? GGT ACA ATG CTG AAT GCC AAA GAG CCC AAA ATC GTC AAT GGT 1464
281 Gly Pro Pro Gly TOn Gly Lye Thr Len Ilie Ala Arg Lye Ilie Gly Thr Met Leu Ann Ala Lye Gin Pro Lye Ilie Val Ann Gly 368
1465 CCA GAA AT? TTG AGT AAG TAC GTT GGT TCT TCA GAA GAA AAC AT? CGT AAT TTA TT? AAG GA? GCA GAA GCA GAA TAT AGG GCC 1548
369 Pro Gin lie Leu let Lys Tyr Val Gly ler ler Gin Gin Ann Ilie Arg Ann Len Phe Lye Asp Ala Gin Ala Gin Tyr Arg Ala 336
Epa I
1549 AAG GGT GAG GAA TCT TCC TTA CA? AT? AT? AT? TIC GA? GAG CTG GA? TC? GTT TTC AAG CAG AGA GGT TCA AGA GGT GA? GGT 1632
337 Lye Gly Gin Gin let let Len His Ilie Ilie Ilie Phe Aep Gin Len Asp let Val Ph. Lye Gin Arg Gly let Arg Gly Asp Gly 364
1633 ACC GGT GTA GGG GAC AAT GTA GTT AAT CAA TTG TTA GCT AAA ATG GA? GTT GA? CAA TTG AAT AAT AT? TTG GTT AT? GGT ATG 1716
365 Thr Gly Val Gly Asp Asn Val Val Asn Gin Len Len Ala Lye Met Asp Val Asp Gin Len Ann Aen Ilie Len Val lie Gly Met 392
1717 ACC AAT CGT AAA GA? TTA ATA GAC AG? GCT CT? TTG CGT CCA GGT AGA TTT GAA GTC CAA GTT GAA A?? CAT TTA CCC GA? GAA 1666
393 TOt 66n Arg Lye Asp Len Ilie Asp let Ala Len Len Arg Pro Gly Arg Phe Gin Val Gin Val Gin lie His Len Pro Asp Gin 426
Upa I
1861 AAA GGA AGA CTC CAA AT? TTC GAC AT? CAG ACG AAG AAA ATG AGG GAA AAT AAT ATG ATG AGC GAC GA? GTT AAC TTA GCT GAG 1884
421 Lys Gly Arg Len Gin lie Phe Asp Ilie Gin Thr Lye Lye Met Arg Gin Ann Ann Met Met let Asp Asp Val Ann Len Ala Gin 448
Hpa I
1885 TTA GCT GCG TTA ACA AAA AAC TTC TCT GGT GCT GAG AT? GAG GGT TTA GIG AAG AG? GCA AG? TCT TTT GCA ATC AAC AAA ACC 1968
449 Len Ala Ala Len Thr Lys Asn Phe let Gly Ala Gin Ilie Gin Gly Len Val Lye let Ala let let POe Ala Ilie Asn Lys TOt 476
1969 GTC AAC ATC GGG AAA GGT GCC ACA AAA CT? AAC ACT AAA GA? ATA GCA AAA CT? AAA GTA ACA AGA GAA GAC TTT TTA AAT GCA 2652
477 Val Asn Ilie Gly Lys Gly Ala TOt Lye Len Asn Tht Lye Asp Ilie Ala Lye Len Lys Vai TOt Arg Gin Asp Phe Len Asn Ala 564
2653 CTC AAC GA? GTT ACT CCC GCT TTT GGG A?? AG? GAA GAA GA? TTG AAA ACA TGT GTG GAA GGT GGA ATG ATG CT? TA? TCC GAA 2136
565 Len Asn Asp Val Tht Pro Ala Ph. Giy lie let Gin Gin Asp Len Lys TOt Cys Val Gin Gly Gly Met Met Lon Tyr let Gin 532
UPS I
2137 CGA GTT AAC TCA ATA TTG AAG AAC GGA GCC CGT TAC GTC CGC CAA GTT CGC GAG AG? GA? AAA TCC AGG TTA GTA TCT CTA TTA 2226
533 Arg Val Asn let Ilie Len Lys Asn Gly Ala Arg Tyr Val Arg Gin Val Arg Gin let Asp Lys let Arg Len Val let Len Len 566
Pot I
2221 ATC CAC GGC CC? GCA GGG TCC GGT AAA ACA GCT TTA GCC GCT GAA AT? GCT TTA AAA TCT GGA TTC CCA TTC ATC AGG TTA AT? 2364
561 lie His Gly Pro Ala Gly let Gly Lys TOt Ala Len Ala Ala Gin Ilie Ala Len Lys let Gly POe Pro Phe Ilie Arg Len lie 588
2365 TCT CCC AAC GAG TTG TCA GGC ATG TCA GAA AGC GCA AAA AT? GCC TAT AT? GA? AAC AC? TTC AGA GA? GCG TAT AAA TCT CCA 2388
589 let Pro Asn Gin Len let Gly Met let Gin let Ala Lys lie Ala Tyr Ilie Asp Asn Thr Ph. Arg Asp Ala Tyr Lys let Pro 616
ipa I
2389 CTA AAC AT? CT? GTT AT? GA? TCG TTA GAG ACT CTA GTT GA? TGG GTA CCA AT? GGT CCA AGA TTC TCT AAT AAC AT? TTA CAA 2472
617 Len Asn Ilie Len Val lie Asp let Len Gin Thr Len Val Asp Trp Val Pro Ilie Gly Pro Arg POe let Ann Asn Ilie Len Gin 644
2473 ATG CTA AAG GTT GCA TTG AAG CGT AAA CCC CCA CAA GAC CGT CGT TTA TTG ATC ATG ACT ACT ACA TCA GCT TAT TCG GTA CT? 2556
645 Met Len Lys Val Ala Len Lye Arg Lys Pro Pro Gin Asp Arg Arg Len Len Ilie Met Thr Tht Tht let Ala Tyr let Val Len 672
2557 CAA CAA ATG GA? A?C TTG AG? TGC TTC GAC AAT GAG ATA GCA GTT CCA AAT ATG ACC AAT TTA GA? GAA TTG AAC AAC GTC ATG 2646
673 Gin Gin Met Asp Ilie Len let Cys Phe Asp Asn Gin Ilie Ala Val Pro Asn Met Thr Asn Len Asp Gin Len Asn Asn Val Met 766
2641 ATA GAA TCA AAC TTT CTT GAC GA? GCT GGT AGA GTT AAA GTT AT? AAT GAA TTA TCA AGG AGC TG? CC? AAC TTC AAT GTC GGT 2724
761 Ile Gin let Asn Phe Len Asp Asp Ala Gly Arg Val Lys Val Ilie Asn Gin Len let Arg let Cys Pro Asn Phe Asn Va1 Gly 728
2725 AT? AAA AAG ACC TTG ACC AAC AT? GAA ACC GCA AGG CAC GA? GAA GA? CCC GTG AAC GAG CT? GTT GAG TTG ATG ACC CAA TCC 2668
729 Ilie Lys Lys Thr Len Thr Asn lie Gin Thr Ala Arg His Asp Gin Asp Pro Val Asn Gin Len Val Gin Len Met Thr Gin let 756
Teraimation Recognition
2889 GCA TAA TTAT?? CAAAT?TTTC ATGTTCTTGT ATTTTTATTC TTTATCCCTT CCAATCAGAA AGGATCTAGT GAACAAGTTC TTTCCTCTAT 2966
757 Ala MSs
Sequeoces Approziasts Poly-Adesylation Addition Sites
2961 GGTATATATT TTAGTGATAA ATTTTATAAA ATTATAAAAC CAAGGCATCC TTTCCTTTTA TTCTGTCATT GGATTCTGCC TGTCATAATT ATCACCACCG 3668
mAnd III
3661 GGTAAAGATG ATAATTTTTC AGTCGCTTTG CCCGAGAAGC TT 3642
FIG. 3. Nucleotide sequence of SECJ8. The nucleotide sequence with translation of the open reading frame. Positions of sites identified
by restriction mapping prior to sequencing are indicated in boldface type, as are the positions of initiator methionine codons at the 5' end of
the open reading frame, the position of the start of the smallest complementing subclone, the position of the transcription start point for SEC18
mRNA, the translation termination codon (TRM), and the transcription recognition sequences and approximate poly(A) addition sites at the
3' end of the clone.
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FIG. 4. (A) Northern blot of SEC18 mRNA. Poly(A)+ RNA (1
,ug) from mid-log-phase SEY2101 cells was run on a 1% agarose-
formaldehyde gel, transferred to GeneScreen, and probed with an
anti-sense SEC18 [32P]RNA that was made with SP6 RNA polymer-
ase. Standards (Stds) were EcoRI- and HindIll-cut lambda DNA
that was end labeled by treating it with [y-32P]ATP and T4 polynu-
cleotide kinase. Sizes (in nucleotides) are indicated to the left of the
gel. (B) Mapping of the 5' end of SEC18 mRNA. An oligonucleotide
complementary to bp 681 to 695 of the DNA sequence was end
labeled with 32p, hybridized to a single-stranded SEC18-M13mpl9
template, and extended with the Klenow fragment to the BamHI
site. The single-stranded probe was fragment purified, hybridized to
25 p.g of total RNA, and digested with mung bean nuclease. The
DNA ladder was obtained by deoxy and dideoxy sequencing reac-
tions by using the end-labeled oligo as primer. The positions of the
first two ATG codons of the open reading frame of the DNA
sequence are indicated to the left of the gel.
minimum complementing SEC18 subclone. Two protein
products (Secl8p) were detected, one of 84,000 daltons and
one of 82,000 daltons (Fig. 5). The larger product corre-
sponded well to the size predicted for translation of our
entire open reading frame. The smaller translation product
may have resulted from either premature termination of
protein translation or initiation of translation at one of the
two ATG codons located at positions 54 and 63 bp down-
stream from the start of the open reading frame. From the
DNA sequence, these smaller open reading frames were
predicted to encode proteins of 82,024 or 81,678 daltons. The
yeast extract translation system that we used does not
normally perform any posttranslational modifications of the
protein products such as signal or prosequence cleavages or
FIG. 5. Identification of Secl8p in vitro and in vivo. (A) Immu-
noprecipitations of Secl8p from 35S-labeled whole-cell yeast ex-
tracts done with preimmune or immune serum in the presence or
absence of tunicamycin, as indicated. (B) Products of in vitro
translation of SP6 RNA polymerase transcripts of the SEC18 open
reading frame. RNAs were made with and without a mRNA cap
analog [m7G(5')ppp(5')G] in the transcription reaction, as indicated.
Translation of the capped message proceeded with much higher
efficiency. kd, Kilodaltons.
the addition of core oligosaccharides which could account
for the multiple forms of the proteins that were produced.
Transcription by SP6 RNA polymerase also has high fidelity
in terms of the site of transcription initiation, so variation in
the 5' end of the RNA template does not seem likely (15).
In order to test whether the protein(s) produced from the
SEC18 open reading frame was also produced in vivo, we
raised antisera to the SEC18 protein. A gene fusion of the
SEC18 open reading frame to the 5' end of the E. coli lacZ
gene was generated by ligating random Bal 31 digestions of
the 3.0-kb BamHI-HindIII fragment into the vector pORF5
(26) (Fig. 6A). Clones which overproduced ,B-galactosidase
activity were initially picked by screening on Xgal plates.
Plasmids from these clones were screened for inserts corre-
sponding to the SECl8 gene by restriction site analysis. In
addition, SDS-PAGE of whole-cell E. coli extracts express-
ing high levels of P-galactosidase activity were stained with
Coomassie blue to visualize the extent of overproduction
and to identify the size of the hybrid proteins (Fig. 6B).
Western blotting of these gels with ,I-galactosidase-specific
antibodies confirmed the identity of hybrid protein bands.
Several gene fusions were created which overproduced
fusion proteins in E. coli that were up to 40,000 daltons
larger than P-galactosidase itself. The fusion joints between
five of these clones and the lacZ sequences were determined
by DNA sequencing, which confirmed that the large open
reading frame of SEC18 was being used. The largest fusion
protein was purified by using preparative SDS-PAGE and
was injected into rabbits to raise antiserum that was reactive
to Secl8p. Antisera were tested initially for reaction to the
Secl8-3-galactosidase fusion protein on Western blots and
were later confirmed to react with the in vitro translation
products of SEC18.
Immunoprecipitation from extracts of 35S-labeled whole
yeast cells with the Secl8p antiserum was able to detect in
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FIG. 6. Production of SEC18-lacZ fusion proteins. (A) Bal 31
digestions of the 3.0-kb BamHI-HindIII fragment were cloned into
the SmaI site of pORF5, a lacZ fusion vector in which a EcoRI-
SmaI-BamHI polylinker was inserted at the amino acid at position 7
to interrupt the reading frame of the lacZ gene. The fragment
marked with double asterisks is clone pORF18-40, which expressed
the largest fusion protein observed. Restriction enzyme abbrevia-
tions: B, BamHI; P, PstI; K, KpnI; Hp, HpaI; H, Hindlll. (B)
Whole-cell extracts of E. coli MclO61, with and without the
pORF18-40 fusion plasmid, were run on SDS-polyacrylamide gels.
A gel stained with Coomassie blue G-250 is shown on the left, and on
the right is a Western blot of a gel identical to that shown on the left
whose proteins were transferred to nitrocellulose by Western blot
and probed with anti-f3-galactosidase antisera. The largest fusion
protein is marked with double asterisks. kd, Kilodaltons.
vivo production of the putative SEC18 gene products. The in
vivo forms of Secl8p were identical in size to those seen by
in vitro translation (Fig. 5). Tunicamycin, which inhibits
N-linked glycosylation, had no effect on the size of the in
vivo proteins that were observed, even though potential sites
for glycosylation were present in the predicted amino acid
sequence at amino acid positions 13, 36, 455, 474, and 689.
This suggests that Secl8p is not translocated across the ER
membrane into the secretory pathway, and thus, it never
comes into contact with the oligosaccharide transferase
enzyme. This was further supported by the hydrophobicity
profile for the predicted Secl8p sequence (Fig. 7), which
showed no evidence for a characteristic hydrophobic signal
sequence at the amino terminus of either the full-length
protein or a protein whose translation began at one of the
two downstream ATG codons at the 5' end of the open
reading frame. In addition, the hydrophobicity profile did not
show any internal regions which would be predicted to span
a membrane or function as internal signal sequences. These
data are most consistent with the fact that Secl8p remained
in the cell cytoplasm. However, these results do not exclude
the association of Secl8p with the cytoplasmic face of an
intracellular organelle membrane.
The two forms of Secl8p seen in vivo also could have
resulted from a posttranslational processing event other than
glycosylation. To address this question, yeast cells were
pulse-labeled for 20 min with 3"SO4 and chased for various
times following the addition of excess cold S04. Whole-cell
extracts were immunoprecipitated with antisera directed
against both Secl8p and CPY, a vacuolar protease which
undergoes processing in the ER, Golgi complex, and vacuole
to give forms which can be distinguished on SDS-polyacryl-
amide gels (28). The results (Fig. 8) indicated that while CPY
is processed normally with a half-time of approximately 5
min, the two forms of Secl8p are maintained in a constant
ratio. This was true for chase periods of up to 2 h (data not
shown). Thus, the two forms of Secl8p do not appear to
result from posttranslational processing of the larger form
into the smaller form or vice versa. It appears that messages
containing the entire open reading frame lead directly to the
production of two forms of the same protein. It is reasonable
to propose that the two forms arise from translation that is
initiated at different points in the open reading frame of the
mRNA.
Results of this study indicate that Secl8p represents a
relatively minor fraction total protein production in yeast
cells. From quantitation of the relative levels of production
of Secl8p and CPY by densitometry, we estimate that
Secl8p is produced at only 1/5th to 1/10th of the level of
CPY. Twentyfold overproduction of Secl8p was observed in
cells harboring the SEC18 gene on a multicopy plasmid
(pSEY8). This suggests that SecJ8 is expressed constitu-
tively and is subject to simple gene dosage control. Experi-
ments looking at the production of Secl8p from the mutant
sec18-J(Ts) allele show that the temperature-sensitive defect
does not result from a decrease in Secl8p expression. In
addition, the temperature-sensitive forms of the protein
appear to show the same stability at the nonpermissive
temperature as wild-type proteins do in pulse-chase labeling
experiments (data not shown).
Intracellular location of Secl8p. Our data predict that
Secl8p is probably a cytoplasmic protein. To determine this
directly, we used cell fractionation techniques with differen-
tial centrifugations to separate yeast cells into membrane-
enclosed and cytoplasmic compartments. Because of its role
in transport between the ER and Golgi complex, we were
especially interested to see whether Secl8p might be asso-
ciated with these compartments. A procedure giving gentle
osmotic lysis was developed which appeared to maintain the
integrity of small organelles such as mitochondria, ER, and
the Golgi complex. Cells were spheroplasted extensively
before they were labeled, and then they were washed and
labeled with Trans35S label in the presence of full osmotic
support (1.2 M sorbitol). To lyse the cells osmotically, cells
were pelleted gently, suspended in a small volume of buffer
with full osmotic support, and then quickly diluted in a buffer
with partial osmotic support (0.25 M sucrose). After an
initial low-speed spin to pellet any unlysed cells, the cleared
lysate was centrifuged sequentially in a microfuge (13,000 x
g for 15 min) and a ultracentrifuge (100,000 x g for 30 min).
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FIG. 7. Hydrophobicity analysis of Secl8p. A hydrophobicity profile of the predicted protein sequence of the SEC18 open reading frame
was calculated by using the values of Hopp and Woods (9) and a window of six amino acids. The positions of charged amino acid residues
are indicated by the tics at the bottom of the figure. Neither the entire open reading frame nor open reading frames starting at 19 or 21 amino
acids into the protein sequence revealed a satisfactory signal sequence or membrane-spanning domain.
Judging from trichloroacetic acid-precipitable counts, only
30 to 50% of cells were lysed by this procedure. However,
no enhancement of any particular form of the markers used
was observed, which suggests that the cleared lysate is
representative of the contents of the cell.
Fractions were immunoprecipitated with Secl8p antisera
under conditions of antibody excess to ensure that compar-
isons of the level of Secl8p present in the various fractions
were valid. Likewise, intermediates in the maturation of
CPY were monitored by using CPY-specific antisera to give
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FIG. 8. Pulse-chase labeling of Secl8p and CPY. Yeast cells
(strain SEY2101; 1 OD6w unit per lane) were labeled for 30 min with
35So4 at 30°C and chased for the indicated times following the
addition of (NH4)2SO4 to a final concentration of 50 mM. Labeling
was stopped by the addition of trichloroacetic acid to 5%, and cell
extracts were immunoprecipitated simultaneously with saturating
amounts of both Secl8p and CPY antisera. (A) Two forms of Secl8p
were not posttranslationally modified into a single species; (B) pl
(ER) and p2(Golgi complex) forms of CPY were chased posttrans-
lationally into the mature vacuolar form. In panel A exposure of the
gel was 2 times longer than that in panel B. From densitometry of
the bands, we estimate that Secl8 is produced at approximately 1/
10th the level of CPY.
markers for the ER, Golgi complex, and vacuolar compart-
ments (28). Immunoprecipitation with antisera against the
P-subunit of mitochondrial Fl-ATPase was also done to
assess the fractionation and intactness of mitochondria in
this procedure. Figure 9 shows an autoradiograph of immu-
noprecipitates of CPY and Secl8p from such an experiment,
which is quantitated in Table 1. The pl and p2 forms of CPY,
which should be localized within the ER and Golgi complex,
respectively, were mainly present (80%) in the 13,000 x g
pellet. A small amount of pl and p2 (20%) was found in the
100,000 x g pellet fraction, perhaps because of some frag-
mentation of these compartments or the material present in
small vesicles in transit between secretory organelles.
Greater than 95% of the P-subunit of mitochondrial Fl-
ATPase was also pelleted in a microfuge. These results
indicate that organelles such as ER, Golgi complex, and
TABLE 1. Quantitation of cell centrifugation"
% of fraction in':
Pellet from: SupernatantFraction _______________________ from 100,000
13,000 x g 100,000 x g x g
centrifugation centrifugation centrifugation
Secl8p <1 44 56
pl and p2 CPY 80 20 <1
Mature CPY <5 <1 >95
Mitochondrial Fl-ATPase p >95 <1 <5
a Quantitation was done by scanning autoradiographs on a laser densitom-
eter (2202; LKB Instruments, Inc., Rockville, Md.) and integration with a
program (GelScan; LKB).
b Percentages represent the amount present in a given fraction divided by
the total of all three fractions. In all cases, the quantitative sum of all three
fractions was within 10% of the quantitation of a similar whole-cell lysate
sample. Samples which were <5 or <1% were either too faint for accurate
quantitation or difficult to resolve because of the presence of contaminating
background bands.
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were represented. The fact that mature CPY was not asso-
ciated with the high-speed pellet fraction indicates that the
Secl8p found in the pellet was not the result of nonspecific
trapping. The data suggest that Secl8p does not interact
directly with ER or the Golgi complex within the cell, or
does so only very transiently. The presence of significant
8e, amounts of Secl8p in the 100,000 x g pellet fraction, along
with a small proportion of the ER and Golgi complex forms
of CPY, suggests that Secl8p may associate with small
vesicles in transit from the ER to the Golgi complex. It is
also possible that Secl8p binds to some large macromolec-
ular complex such as the cytoskeletal network which could
be pelleted at the higher g force. The possibility remains that
the association of Secl8p with the 100,000 x g pellet may be
an artifact caused by aggregation of the protein or binding to
_p2 membrane fragments. Nevertheless, the association of
-p1 Secl8p with the high-speed pellet may provide a clue to the
_o-CPY functional role of Secl8 within the cell. Note also that there
was not a preferential association of one or the other form of
Secl8p with the pellet fraction, which suggests that the two
protein forms may be functionally equivalent.
Q-CPY
FIG. 9. Secl8p fractionates between a high-speed membrane and
supematant fractions. Yeast cells (strain SEY2101) were sphero-
plasted with oxylyticase, labeled with Trans35S label, and lysed
osmotically. The lysate was pelleted at 2,000 x g to remove any
unbroken cells, and the supematant was pelleted sequentially at
13,000 x g and 100,000 x g. From left to right, the first lane of each
panel shows immunoprecipitation from a fraction of the whole-cell
lysate, the second lane from a 13,000 x g pellet, the third lane from
a 100,000 x g pellet, and the fourth lane from trichloroacetic
acid-precipitated proteins from the 100,000 x g supernatant. (A)
Immunoprecipitation with Secl8p antiserum; (B) subsequent immu-
noprecipitation with CPY antiserum. pl and p2 represent the ER
and Golgi complex intermediates, respectively, in the processing of
CPY to its mature form. Extra bands that were present in the lane
with the Secl8p 100,000 x g pellet and the lane with the CPY
whole-cell lysate were not reproducible and probably represented
some nonspecific cross-reaction of the antiserum that was used for
immunoprecipitation. kd, Kilodaltons.
mitochondria appear to remain largely intact by this lysis
procedure and are recovered predominantly in the 13,000 x
g pellet. In contrast, lysis of whole cells by a more vigorous
procedure (vortexing in the presence of glass beads) led to 60
to 80% release of the ER, Golgi complex, and mitochondrial
markers into the supernatant fraction (data not shown). Very
little (<5%) of the mature CPY, a protease that is present in
the lumen of the yeast vacuole, was associated with the
13,000 x g pellet fraction. The yeast vacuole is a very fragile
compartment which we would expect to be lysed without full
osmotic support. This was confirmed by the presence of
mature CPY predominantly (>95%) in the 100,000 x g
supernatant fraction.
Secl8p was found in significant amounts in both the
100,000 x g pellet (44%) and supernatant (56%) fractions.
Little (<1%), if any, of Secl8p was associated with the
microfuge pellet fraction. Since Secl8 is implicated in trans-
port between the ER and the Golgi complex, it is somewhat
surprising that it would be found in a high-speed pellet
fraction in which small vesicles would presumably be recov-
ered and yet not be associated with a fraction (the 13,000 x
g pellet) in which the bulk of the ER and the Golgi complex
DISCUSSION
As a first step in understanding the role of the yeast SEC18
gene product in secretory protein transport between the ER
and the Golgi complex, we cloned and sequenced the gene.
A single 3.0-kb DNA fragment was isolated that comple-
mented the temperature-sensitive defect exhibited by sec18-
I mutant yeast cells. This DNA segment mapped genetically
to the SEC18 locus. RNA probes derived from the cloned
segment detected one major 2,500-nucleotide poly(A)+
mRNA on Northern blots (Fig. 4A). Consistent with this, the
major open reading frame (2,271 bp) in the SEC18 clone was
predicted to encode a protein of 84 kilodaltons. Somewhat
surprisingly, two protein products of this open reading frame
were observed both from in vitro translation extracts pro-
grammed with SEC18 mRNA and from in vivo 35S-labeled
yeast cell extracts (Fig. 5). Disruption of this open reading
frame indicates that the function of Secl8p is essential for
cell viability. Spores containing a disrupted SEC18 gene
were able to germinate but only underwent, at most, one
round of cell division in the absence of SEC18 expression.
Several aspects of SEC18 gene expression were novel and
unexpected. First, sequences upstream from the site of
transcription initiation did not appear to be necessary for
SEC18 expression. A subclone which contained only five
nucleotides preceding the start point of transcription was
sufficient for the expression of adequate levels of Secl8p for
the complementation of the secl8-1 mutation. Complemen-
tation with this subclone was observed when several dif-
ferent high- and low-copy-number yeast shuttle vectors were
used, suggesting that aberrant expression of this subclone in
a particular plasmid context is not the cause of the observed
complementation.
Second, there were two sequences just upstream of the
open reading frame, TATATT at bases 516 to 522 and
TATAAA at 529 to 535, which could possibly function as
TATA elements for transcriptional control. Yet, these se-
quences were actually within the transcribed region itself
rather than at the normal position that TATA elements
usually occupy 40 to 120 bp 5' of the site of transcription
initiation (29). This, along with the fact that the transcribed
region alone appeared to be sufficient for gene expression,
raises the possibility that SEC18 promoter elements may
function from within the gene itself. Alternatively, these
116kd-
97 kd-
Sec18p _ ^
68 kd-
40 kd-
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TATA elements formed part of a cryptic promoter leading to
expression of the minimum complementing fragment.
Third, the SEC18 gene produced two proteins from tran-
scripts that appeared to start at a single site. Other cases of
the expression of multiple forms of protein from a single
yeast gene have been observed, such as the production of
cytoplasmic and secreted forms of invertase from the yeast
SUC2 gene (2). However, these were caused by multiple
sites of transcription initiation leading to messages which
had different AUG codons of the open reading frame at their
5' ends. There is a precedent for translation initiating at
multiple AUG codons in a yeast mRNA. The GCN4 gene of
S. cerevisiae, whose protein product controls the transcrip-
tion of a large number of amino acid biosynthesis genes, uses
translation initiation at multiple AUG codons in the mRNA
as a translational control of its expression (17). Four short
open reading frames of an AUG codon followed by two to
three codons are present in an -600 nucleotide leader region
of the GCN4 mRNA and act to inhibit the translation of
GCN4 under nonstarvation conditions (17). In contrast,
SEC18 appeared to have only one major class of mRNA with
a short 5'-untranslated leader and a set of three AUG codons
early in the mRNA that were all in frame with the major open
reading frame of the gene, yet two forms of the same protein
with different sizes were produced (Fig. 4 and 5). The two
forms of the protein did not appear to be the result of
posttranslational processing events (Fig. 8). The size of the
smaller protein product corresponded well to the predicted
size of translation products initiated from AUGs that were 19
or 21 codons downstream of the first AUG codon of the open
reading frame, leading us to suggest that the smaller protein
product arises from translation initiating at one of these
downstream codons. In vitro mutagenesis of the different
AUG codons in SEC18 should reveal whether translation
indeed starts at more than one site or whether another
mechanism is responsible for the multiple forms of protein
being produced. In addition, such in vitro mutagenesis
should permit one to test whether the two Secl8 proteins are
functionally equivalent. It is tempting to speculate that the
two isoforms of Secl8p could have different functional roles
in directing secretory protein traffic.
The intracellular location of Secl8p was analyzed to gain
insight into the functional role that Secl8 plays in the
secretory pathway. The predicted amino acid sequences of
Secl8 proteins did not indicate any targeting signal which
would allow Secl8p to be translocated across the ER mem-
brane. The conclusion that Secl8p remains in the cytoplasm
was reinforced by the observation that Secl8p was not
modified with core oligosaccharides (Fig. 5), a function
which is carried out within the ER, even though potential
sites for N-linked glycosylation are present in the amino acid
sequence. Results of cellular fractionation experiments by
an osmotic lysis procedure, which was able to maintain the
integrity of organelles such as mitochondria, ER, and the
Golgi complex, indicated that Secl8p is not tightly associ-
ated with the bulk of ER or the Golgi complex (Fig. 9).
However, centrifugation at higher g forces revealed a distri-
bution of Secl8p between the pellet and soluble fractions.
This observation suggests that Secl8p may be associated
with small vesicles or a macromolecular complex that is
important in intracellular secretory protein transport.
The phenotype of secl8-1 mutant yeast cells suggests a
direct role for Secl8p in the transport of secretory proteins
between the ER and the Golgi complex. At the nonpermis-
sive temperature, there was a rapid accumulation of newly
synthesized secretory proteins which underwent all of the
modifications characteristic of the ER (signal sequence
cleavage and addition of core oligosaccharides). No modifi-
cation or processing events known to occur after that of the
ER were observed in the secl8-1 mutant. Therefore, it
appears that a block exists in the transfer of secretory
proteins from the ER to the Golgi complex. Possible func-
tions for Secl8p might include the packaging of proteins into
transport vesicles, a role in the budding of such vesicles, the
transport of vesicles to the target organelle, recognition or
fusion of these vesicles with the Golgi complex, or the
recycling of transport components back to the ER. The
cytoplasmic location of Secl8p rules out any direct role in
the sorting and selection of proteins from the lumen of the
ER for transport to the Golgi complex. Our data, which
show an association of Secl8p with a high-speed pellet
fraction, suggest that Secl8p may function in the formation
of small transport vesicles at the ER or in their transport and
targeting to Golgi complex membranes. The recent develop-
ment of efficient in vitro transport assays for ER to Golgi
complex protein traffic (1) may provide a means to examine
directly the functional role of Secl8p in this critical interor-
ganelle transport event, potentially in both yeast and mam-
malian reconstituted systems.
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